ReviewJournal of virology2026
Lost in translation: interferon-stimulated genes targeting flavivirus protein synthesis.
Review in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Flaviviruses are positive-sense RNA viruses that rely entirely on host translation machinery to express their genome, making protein synthesis a central point of vulnerability. Interferon-stimulated genes (ISGs) exploit this dependence through diverse and mechanistically distinct strategies. PKR and IFIT proteins interfere primarily with translation initiation by targeting initiation factors or cap recognition, whereas SLFN11 and SAMD9L impair elongation through codon- and tRNA-dependent mechanisms. In parallel, ZAP, SHFL, and ISG20 inhibit translation by excluding viral RNAs from ribosomes or promoting their degradation. These antiviral activities highlight that ISG-mediated restriction is often highly selective, targeting viral RNAs on features such as cap structure, nucleotide composition, codon usage, and RNA folding. As a result, translation emerges as a central interface of host-virus conflict, where subtle differences between viral and cellular mRNAs can be exploited to achieve potent antiviral effects while preserving host protein synthesis. This minireview highlights recent advances in the identification and characterization of ISGs that restrict flavivirus protein synthesis and integrates them into a unified framework based on their primary mechanism of action. Emphasizing how host defenses target multiple stages of translation provides a conceptual basis for understanding how innate immunity controls flavivirus replication and highlights viral translation as a promising target for selective antiviral strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.